The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

Study presented at ESGO 2025 highlights the accuracy of preoperative tumour size assessment in stage IB2 cervical cancer and ...

The addition of AK104 to concurrent chemoradiotherapy improved survival outcomes for patients with locally advanced cervical ...

Many of the annual cervical cancer cases originate in countries ... Those samples are sent out for pathology and the results are used for follow-up recommendations. If the diagnosis comes back ...

"Our findings suggest that, in the condition of negative sentinel lymph nodes, omitting pelvic lymphadenectomy does not ...

These data support vaccinating children at the routinely recommended ages as a cancer prevention measure. Cervical precancer rates dropped precipitously among young women who underwent screening ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

irrespective of PD-L1 expression level or tumor histology. Although cervical cancer is often curable when detected early and effectively managed, advanced or metastatic disease – when the cancer ...

Cytology has low sensitivity for cervical cancer pre-cursors, has low reproducibility ... and the American Society for Colposcopy and Cervical Pathology (ASCCP) on the use of primary hrHPV testing as ...